Letizia C
Solvay Pharmaceuticals, Incorporated, Marietta, Georgia 30062, USA.
Qual Assur. 1995 Mar;4(1):68-74.
The economic pressures of cost containment, pricing competition, and managed care have bootstrapped the application of health economic evaluation into the specialized area of pharmacoeconomics. The rapid development of the field has lead to criticism within the discipline and skepticism from consumers of pharmacoeconomic studies. The need for consensus upon standards of design and analysis will result in guidelines and more stringent peer review. The relative merits of current approaches are reviewed with respect to the limitations and generalizability of each type of study and common pitfalls in the design, analysis, and promotion of pharmacoeconomic studies. Future trends and regulatory issues are discussed. Finally, the role of pharmacoeconomics in drug development and marketing is evaluated.
成本控制、定价竞争和管理式医疗带来的经济压力推动了健康经济评估在药物经济学这一专业领域的应用。该领域的快速发展引发了学科内部的批评以及药物经济学研究消费者的质疑。达成设计和分析标准共识的需求将催生指南以及更严格的同行评审。本文回顾了当前方法的相对优点，涉及各类研究的局限性、可推广性以及药物经济学研究在设计、分析和推广过程中常见的陷阱。还讨论了未来趋势和监管问题。最后，评估了药物经济学在药物研发和营销中的作用。
